TP53 and neoplasm: Molecular classification is extremely useful in grade 3 endometrioid carcinomas, intercepting POLE-mut and p53-mut neoplasms, which represent the prognostic extremes of the molecular spectrum, with sometimes overlapping morphology but opposite implications in medical management [87,88].